AstraZeneca

How an AstraZeneca exec is leading the charge in the next immuno-oncology era
Pharma Voice
Fri, 08/18/23 - 10:15 am
AstraZeneca
immuno-oncology
FDA warns AstraZeneca over false advertising of COPD drug
Beckers Hospital Review
Thu, 08/17/23 - 09:52 am
AstraZeneca
COPD
FDA
Breztri Aerosphere
DTC advertising
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
Wed, 08/16/23 - 10:16 am
CMS
Medicare
drug pricing
Bristol Myers Squibb
Janssen
Merck
Pfizer
Amgen
Boehringer Ingelheim
Pharmacyclics
AstraZeneca
Astellas
GSK
Eco-minded AstraZeneca doubles down on renewable energy push in Sweden
Fierce Pharma
Wed, 08/9/23 - 09:58 pm
AstraZeneca
sustainability
Sweden
Spotlight – Nash in 2023 and beyond
EP Vantage
Thu, 08/3/23 - 10:03 am
NASH
Boehringer Ingelheim
Zealand Pharma
Akero Therapeutics
Axcella Health
Eli Lilly
Pfizer
Ionis Pharmaceuticals
Cascade
AstraZeneca
Gilead Sciences
Novo Nordisk
Ascletis Pharma
MediciNova
Filings signal: Despite Covid losses, pharma earnings are promising
Clinical Trials Arena
Wed, 08/2/23 - 11:32 am
Takeda
AstraZeneca
Roche
earnings
COVID-19
Bristol Myers, AstraZeneca settle PD-1, CTLA-4 cancer immunotherapy patent suits for $510M
Fierce Pharma
Tue, 08/1/23 - 12:02 pm
Bristol Myers Squibb
AstraZeneca
cancer immunotherapy
legal
patents
Patent Infringement
Enhertu offers survival benefits in Phase II solid tumour trial
Clinical Trials Arena
Sat, 07/29/23 - 10:42 pm
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
solid tumors
AstraZeneca adds Latin America to Ionis ATTR partnership for $20M
Fierce Biotech
Fri, 07/28/23 - 11:48 am
AstraZeneca
Ionis Pharmaceuticals
Latin American
eplontersen
ATTR
AstraZeneca buys Pfizer’s early gene therapy work for up to $1B
BioPharma Dive
Fri, 07/28/23 - 10:45 am
AstraZeneca
Pfizer
M&A
gene therapy
AstraZeneca enlists SK Chemicals to produce diabetes combo drug Sidapvia
Fierce Pharma
Mon, 07/24/23 - 09:42 pm
AstraZeneca
SK Chemicals
Korea
Sidapvia
diabetes
drug manufacturing
Scratching the surface of the urticaria pipeline
EP Vantage
Thu, 07/20/23 - 10:00 am
chronic urticaria
Sanofi
Dupixent
Regeneron
Novartis
Roche
Xolair
Allakos
AstraZeneca
Celldex Therapeutics
Pieris wields axe after losing AZ as partner for elarekibep
Pharmaphorum
Wed, 07/19/23 - 10:13 am
Pieris
AstraZeneca
elarekibep
layoffs
CDC vaccine committee sets August date to weigh use of Sanofi, AZ's RSV antibody Beyfortus
Fierce Pharma
Tue, 07/18/23 - 10:06 pm
CDC
Sanofi
AstraZeneca
RSV
Beyfortus
FDA Approves Sanofi and AstraZeneca’s RSV Antibody for Newborns, Infants
BioSpace
Mon, 07/17/23 - 07:00 pm
Sanofi
AstraZeneca
Beyfortus
nirsevimab
RSV
infants
pediatric
FDA
AstraZeneca stock slides as pivotal lung cancer readout on Daiichi-partnered ADC spooks investors
Fierce Biotech
Mon, 07/3/23 - 11:40 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
clinical trials
non-small cell lung cancer
AstraZeneca’s liver cancer treatment shows ‘continued survival benefit’ in phase 3 trial
Biopharma Reporter
Mon, 07/3/23 - 10:46 am
AstraZeneca
Imfinzi
liver cancer
clinical trials
AstraZeneca sows $400M investment in push to plant 200M trees by 2030
Fierce Pharma
Wed, 06/28/23 - 10:49 am
AstraZeneca
environmental concerns
ESG
5 FDA decisions to watch in the third quarter
BioPharma Dive
Mon, 06/26/23 - 10:04 am
FDA
SAGE Therapeutics
Biogen
zuranolone
Eisai
Leqembi
Sanofi
AstraZeneca
nirsevimab
Iveric Bio
Zimura
Alnylam
Onpattro
Alphabet's quantum spinoff starts working with AstraZeneca, Sanofi to accelerate R&D
Fierce Biotech
Fri, 06/23/23 - 10:01 am
Alphabet
SandboxAQ
AstraZeneca
Sanofi
R&D
funding
molecular simulation
artificial intelligence

Pages